Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» immuno-oncology
immuno-oncology
Novartis' new CAR-T hopeful looks safe in an early solid tumor study
Fierce Biotech
Mon, 04/20/15 - 11:53 am
Novartis
CAR-T
immuno-oncology
Big Pharma-backed Dutch immuno-oncology player eyes €100M Nasdaq IPO
Fierce Biotech
Thu, 04/9/15 - 10:01 am
IPOs
Merus
JNJ
Novartis
Pfizer
immuno-oncology
Roche open to alliances in hunt for cancer drug combinations
Yahoo/Reuters
Wed, 04/1/15 - 08:39 am
Roche
immuno-oncology
Novartis bulks up in immuno-oncology with a $750M Aduro deal
Fierce Biotech
Mon, 03/30/15 - 09:57 am
Novartis
Aduro BioTech
immuno-oncology
J&J partner Aduro rides the immuno-oncology wave with $86M IPO
Fierce Biotech
Thu, 03/12/15 - 11:08 am
JNJ
Aduro BioTech
immuno-oncology
IPOs
Has Pfizer Inc. Finally Solved Its Immuno-oncology Problem?
Motley Fool
Wed, 02/18/15 - 10:56 am
Pfizer
immuno-oncology
AstraZeneca
Bristol-Myers Squibb
Merck
Roche
Roche's late-stage R&D strategy tests the enthusiasm for immuno-oncology
Fierce Biotech
Wed, 01/28/15 - 01:11 pm
Roche
R&D
immuno-oncology
Curis aims for anti-cancer drugs that use the immune system and come in a pill
Bizjournals.com
Thu, 01/22/15 - 02:37 pm
Curis
immuno-oncology
The Emergence Of PV-10, And Provectus Biopharmaceuticals
Seeking Alpha
Wed, 01/21/15 - 11:51 am
PV-10
Provectus
immuno-oncology
8 Biotech Stock Controversies Emerging From 'JPM15' Conference
TheStreet.com
Tue, 01/20/15 - 11:33 am
JPMHC 2015
drug pricing
CAR-T
biotech
Gilead Sciences
immuno-oncology
Duchenne Muscular Dystrophy
Incyte, Agenus partner on immuno-oncology targets in $410M deal
Fierce Biotech
Fri, 01/9/15 - 09:56 am
Incyte
Agenus
immuno-oncology
Shake-up at AstraZeneca as two immuno-oncology leaders leave
Yahoo/Reuters
Mon, 01/5/15 - 04:02 pm
AstraZeneca
immuno-oncology
A new era of immuno-oncology has arrived
Fierce Biotech
Fri, 12/26/14 - 10:17 am
immuno-oncology
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Roche
Amgen
AstraZeneca
Northwest Biotherapeutics: An Analysis Of What We Know About DCVax Direct
Seeking Alpha
Mon, 12/1/14 - 09:17 am
DCVax Direct
Northwest Biotherapeutics
cancer
immuno-oncology
Dynavax Initiates Phase 1/2 Study of TLR-9 Agonist Immunotherapy in B-Cell Lymphoma
Yahoo
Mon, 10/13/14 - 07:26 am
Dynavax
TLR-9
immuno-oncology
B-cell lymphoma
SD-101
Novartis taps Oxford BioMedica in $90M immuno-oncology deal
Fierce Biotech
Fri, 10/10/14 - 11:50 am
Novarti
Oxford BioMedica
immuno-oncology
lentivirus
Adaptimmune raises $104 mln to develop immune-system cancer drugs
Yahoo/Reuters
Wed, 09/24/14 - 09:39 pm
Adaptimmune
immuno-oncology
Merck KGaA seeks partner for immuno-oncology drug by year-end
Yahoo/Reuters
Thu, 09/18/14 - 08:55 am
Merck KGaA
immuno-oncology
anti-PD-L1
Advaxis, Merck to test immune therapies against prostate cancer
Yahoo/Reuters
Mon, 08/25/14 - 08:19 am
Advaxis
Merck
prostate cancer
immuno-oncology
Forget Earnings: Catalysts Incoming for Novartis Stock
Motley Fool
Thu, 07/17/14 - 04:11 pm
earnings
Novartis
LCZ696
immuno-oncology
Co-Stim
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
next ›
last »